NuCana (NCNA) Change in Account Payables (2017 - 2025)
NuCana's (NCNA) quarterly Change in Account Payables came in at -$1.5 million in Q4 2025, up 64.64% year-on-year from -$920241.2 in Q4 2024, and down 299.43% quarter-over-quarter from $759690.9 in Q3 2025.
NuCana (NCNA) Change in Account Payables (2017 - 2025) Analysis & Trends
NuCana has disclosed Change in Account Payables across 9 years of filings, most recently posting -$1.5 million for Q4 2025.
- Change in Account Payables for Q4 2025 came in at -$1.5 million, up 64.64% year-over-year; the trailing twelve-month figure through Dec 2025 was -$5.1 million (down 466.9% YoY), and the FY2025 annual result was -$2.9 million, down 236.08% from the prior year.
- Change in Account Payables came in at -$1.5 million for Q4 2025 at NuCana, down from $759690.9 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $3.0 million in Q1 2024 to a low of -$4.3 million in Q4 2024.
- The 5-year median for Change in Account Payables is $174225.1 (2024), against an average of -$221843.8.
- Peak annual rise in Change in Account Payables reached 3041.58% in 2021, while the deepest fall reached 293.34% in 2021.
- NuCana's Change in Account Payables stood at -$2.8 million in 2021, then soared by 74.72% to -$702697.3 in 2022, then tumbled by 217.75% to -$2.2 million in 2023, then tumbled by 91.88% to -$4.3 million in 2024, then jumped by 64.64% to -$1.5 million in 2025.
- The last three Change in Account Payables figures came in at -$1.5 million (Q4 2025), $759690.9 (Q3 2025), and -$4.3 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -9.42 Mn |
| 10 | NuCana | 29.13 Bn | 29.13 Bn | - | -1.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.52 Mn |
| Dec 31, 2025 | -1.52 Mn |
| Sep 30, 2025 | 759,690.89 |
| Sep 30, 2025 | 759,690.89 |
| Dec 31, 2024 | -4.28 Mn |
| Dec 31, 2024 | -4.28 Mn |
| Sep 30, 2024 | -85,753.81 |
| Sep 30, 2024 | -85,753.81 |
| Jun 30, 2024 | 434,203.94 |
| Jun 30, 2024 | 434,203.94 |
| Mar 31, 2024 | 3.03 Mn |
| Mar 31, 2024 | 3.03 Mn |
| Dec 31, 2023 | -2.23 Mn |
| Dec 31, 2023 | -2.23 Mn |
| Sep 30, 2023 | 627,008.97 |
| Sep 30, 2023 | 627,008.97 |
| Jun 30, 2023 | -1.27 Mn |
| Jun 30, 2023 | -1.27 Mn |
| Mar 31, 2023 | 1.08 Mn |
| Mar 31, 2023 | 1.08 Mn |